PAREXEL International (PRXL) Earns Daily Media Sentiment Rating of 0.06
News stories about PAREXEL International (NASDAQ:PRXL) have been trending somewhat positive recently, according to Accern. The research firm scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PAREXEL International earned a news sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 45.8177987022295 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Shares of PAREXEL International (NASDAQ PRXL) traded down $0.02 during mid-day trading on Friday, hitting $88.08. The stock had a trading volume of 7,021,100 shares, compared to its average volume of 1,041,144. PAREXEL International has a fifty-two week low of $51.16 and a fifty-two week high of $88.10. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 1.01.
ILLEGAL ACTIVITY NOTICE: “PAREXEL International (PRXL) Earns Daily Media Sentiment Rating of 0.06” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://theolympiareport.com/2018/01/05/parexel-international-prxl-earns-daily-media-sentiment-rating-of-0-06.html.
PAREXEL International Company Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.
Receive News & Ratings for PAREXEL International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International and related companies with MarketBeat.com's FREE daily email newsletter.